NASDAQ: BWAY
Brainsway Ltd Stock Forecast, Predictions & Price Target

Analyst price target for BWAY

Based on 1 analyst offering 12 month price targets for Brainsway Ltd

Min Forecast
$16.00+103.56%
Avg Forecast
$16.00+103.56%
Max Forecast
$16.00+103.56%

Should I buy or sell BWAY stock?

Based on 1 analyst offering ratings for Brainsway Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their BWAY stock forecasts and price targets.

BWAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-12

1 of 1

Forecast return on equity

Is BWAY forecast to generate an efficient return?

Company
10.4%
Industry
20.08%
Market
76.96%
BWAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BWAY forecast to generate an efficient return on assets?

Company
6.9%
Industry
10.81%
BWAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BWAY earnings per share forecast

What is BWAY's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.14-15.63%
Avg 2 year Forecast
$0.20+21.88%
BWAY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BWAY revenue forecast

What is BWAY's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$49.9M+21.55%
Avg 2 year Forecast
$59.6M+45.33%
BWAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BWAY earnings growth forecast

How is BWAY forecast to perform vs Medical Devices companies and vs the US market?

Company
-15.62%
Industry
52.1%
Market
71.14%
BWAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BWAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BWAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BWAY revenue growth forecast

How is BWAY forecast to perform vs Medical Devices companies and vs the US market?

Company
21.55%
Industry
7.78%
Market
59.56%
BWAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BWAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BWAY vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BWAY$7.86$16.00+103.56%Buy
BDMD$5.55N/AN/A
SGHT$2.76$3.83+38.88%Buy
CATX$1.92$12.88+570.57%Buy
MYO$4.28$10.50+145.33%Buy

Brainsway Stock Forecast FAQ

Is Brainsway Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BWAY) stock is to Buy BWAY stock.

Out of 1 analyst, 0 (0%) are recommending BWAY as a Strong Buy, 1 (100%) are recommending BWAY as a Buy, 0 (0%) are recommending BWAY as a Hold, 0 (0%) are recommending BWAY as a Sell, and 0 (0%) are recommending BWAY as a Strong Sell.

If you're new to stock investing, here's how to buy Brainsway stock.

What is BWAY's earnings growth forecast for 2025-2026?

(NASDAQ: BWAY) Brainsway's forecast annual earnings growth rate of -15.62% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 52.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Brainsway's earnings in 2025 is $2,921,000.On average, 4 Wall Street analysts forecast BWAY's earnings for 2025 to be $4,487,696, with the lowest BWAY earnings forecast at $2,659,375, and the highest BWAY earnings forecast at $5,983,594.

In 2026, BWAY is forecast to generate $6,482,227 in earnings, with the lowest earnings forecast at $2,991,797 and the highest earnings forecast at $9,972,657.

What is BWAY's revenue growth forecast for 2025-2026?

(NASDAQ: BWAY) Brainsway's forecast annual revenue growth rate of 21.55% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.

Brainsway's revenue in 2025 is $41,016,000.On average, 3 Wall Street analysts forecast BWAY's revenue for 2025 to be $1,657,322,575, with the lowest BWAY revenue forecast at $1,628,867,261, and the highest BWAY revenue forecast at $1,687,705,936.

In 2026, BWAY is forecast to generate $1,981,566,886 in revenue, with the lowest revenue forecast at $1,928,046,962 and the highest revenue forecast at $2,021,125,091.

What is BWAY's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: BWAY) forecast ROA is 6.9%, which is lower than the forecast US Medical Devices industry average of 10.81%.

What is BWAY's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BWAY price target, the average BWAY price target is $16.00, with the highest BWAY stock price forecast at $16.00 and the lowest BWAY stock price forecast at $16.00.

The Wall Street analyst predicted that Brainsway's share price could reach $16.00 by Mar 12, 2026. The average Brainsway stock price prediction forecasts a potential upside of 103.56% from the current BWAY share price of $7.86.

What is BWAY's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BWAY) Brainsway's current Earnings Per Share (EPS) is $0.16. On average, analysts forecast that BWAY's EPS will be $0.14 for 2025, with the lowest EPS forecast at $0.08, and the highest EPS forecast at $0.18. In 2026, BWAY's EPS is forecast to hit $0.20 (min: $0.09, max: $0.30).

What is BWAY's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: BWAY) forecast ROE is 10.4%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.